Aevi Genomic Medicine, Inc. Debt to Equity Ratio 2012-2019 | GNMX
Current and historical debt to equity ratio values for Aevi Genomic Medicine, Inc. (GNMX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Aevi Genomic Medicine, Inc. debt/equity for the three months ending September 30, 2019 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2019-09-30 | $0.01B | $-0.00B | -1.81 |
| 2019-06-30 | $0.00B | $0.00B | 11.11 |
| 2019-03-31 | $0.00B | $0.00B | 1.05 |
| 2018-12-31 | $0.00B | $0.01B | 0.55 |
| 2018-09-30 | $0.01B | $0.01B | 0.47 |
| 2018-06-30 | $0.01B | $0.02B | 0.32 |
| 2018-03-31 | $0.01B | $0.02B | 0.21 |
| 2017-12-31 | $0.00B | $0.03B | 0.14 |
| 2017-09-30 | $0.01B | $0.01B | 0.68 |
| 2017-06-30 | $0.01B | $0.02B | 0.28 |
| 2017-03-31 | $0.01B | $0.03B | 0.22 |
| 2016-12-31 | $0.01B | $0.04B | 0.16 |
| 2016-09-30 | $0.01B | $0.04B | 0.13 |
| 2016-06-30 | $0.00B | $0.05B | 0.08 |
| 2016-03-31 | $0.00B | $0.04B | 0.09 |
| 2015-12-31 | $0.00B | $0.05B | 0.08 |
| 2015-09-30 | $0.01B | $0.01B | 1.13 |
| 2015-06-30 | $0.00B | $0.02B | 0.18 |
| 2015-03-31 | $0.00B | $0.02B | 0.15 |
| 2014-12-31 | $0.01B | $0.03B | 0.16 |
| 2014-09-30 | $0.00B | $0.01B | 0.29 |
| 2014-06-30 | $0.00B | $0.01B | 0.32 |
| 2014-03-31 | $0.01B | $0.02B | 0.30 |
| 2013-12-31 | $0.01B | $0.02B | 0.25 |
| 2013-09-30 | $0.01B | $0.02B | 0.29 |
| 2013-06-30 | $0.00B | $0.03B | 0.16 |
| 2013-03-31 | $0.01B | $0.03B | 0.18 |
| 2012-12-31 | $0.01B | $0.00B | 2.99 |
| 2012-09-30 | $0.01B | $0.00B | 2.22 |
| 2012-06-30 | $0.01B | $0.00B | 2.01 |
| 2012-03-31 | $0.01B | $0.00B | 8.72 |
| 2011-12-31 | $0.00B | $0.00B | 1.29 |
| 2011-09-30 | $0.01B | $0.01B | 1.07 |
| 2011-06-30 | $0.01B | $0.01B | 0.63 |
| 2011-03-31 | $0.00B | 0.00 | |
